News

IOL Chemicals & Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 2 September 2026.

Net profit of IOL Chemicals & Pharmaceuticals rose 69.19% to Rs 53.16 crore in the quarter ended March 2026 as against Rs 31.42 crore during the previous quarter ended March 2025. Sales rose 17.37% to Rs 619.45 crore in the quarter ended March 2026 as against Rs 527.78 crore during the previous quarter ended March 2025.For the full year,net profit rose 36.18% to Rs 137.64 crore in the year ended March 2026 as against Rs 101.07 crore during the previous year ended March 2025. Sales rose 11.54% to Rs 2319.06 crore in the year ended March 2026 as against Rs 2079.21 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales619.45527.78 17 2319.062079.21 12 OPM %14.9311.89 -11.609.73 - PBDT91.1063.25 44 275.80209.95 31 PBT70.8144.70 58 195.57137.96 42 NP53.1631.42 69 137.64101.07 36 Powered by Capital Market - Live News

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 May 2026.

Net profit of IOL Chemicals & Pharmaceuticals rose 0.24% to Rs 20.58 crore in the quarter ended December 2025 as against Rs 20.53 crore during the previous quarter ended December 2024. Sales rose 10.91% to Rs 580.39 crore in the quarter ended December 2025 as against Rs 523.30 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales580.39523.30 11 OPM %9.878.96 - PBDT58.9446.48 27 PBT38.7627.80 39 NP20.5820.53 0 Powered by Capital Market - Live News

IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 11 February 2026, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live News